ANDA 90431, held by Rising Pharmaceuticals. Doxycycline Hyclate.
As of Nov 21, 2026, ANDA 90431 (Doxycycline Hyclate), held by Rising Pharmaceuticals, was first approved by FDA on Dec 28, 2010, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 28, 2010 | Original application | Approved | None posted |
| Doxycycline HyclateEQ 75MG BASE · tablet, delayed release;oral | Doxycycline Hyclate | Discontinued |
| Doxycycline HyclateEQ 100MG BASE · tablet, delayed release;oral | Doxycycline Hyclate | Discontinued |
| Doxycycline HyclateEQ 50MG BASE · tablet, delayed release;oral | Doxycycline Hyclate | Discontinued |
| Doxycycline HyclateEQ 80MG BASE · tablet, delayed release;oral | Doxycycline Hyclate | Discontinued |
| Doxycycline HyclateEQ 200MG BASE · tablet, delayed release;oral | Doxycycline Hyclate | Discontinued |
| Apr 9, 2026 | Supplement 13Labeling · Standard review | Approved | None posted |
| Apr 9, 2026 | Supplement 14Labeling · Standard review | Approved | None posted |
| Apr 9, 2026 | Supplement 20Labeling · Standard review | Approved | None posted |
| Apr 9, 2026 | Supplement 24Labeling · Standard review | Approved | None posted |
| May 23, 2016 | Supplement 10Manufacturing | Approved | |
| May 19, 2016 | Supplement 4Manufacturing | Approved | |
| Apr 29, 2016 | Supplement 5Manufacturing | Approved | |
| Dec 11, 2015 | Supplement 9Labeling · Standard review | Approved | None posted |
| Sep 16, 2015 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jan 16, 2015 | Supplement 6Labeling · Standard review | Approved | None posted |
| Dec 15, 2011 | Supplement 2Labeling | Approved | None posted |
| Dec 28, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters